Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/31322286http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31322286http://www.w3.org/2000/01/rdf-schema#comment"

Background and purpose

In non-small-cell lung carcinoma (NSCLC) patients, the L858R/T790M mutation of the epithelial growth factor receptor (EGFR) is a major cause of acquired resistance to EGFR-TKIs treatment that limits their therapeutic efficacy. Identification of drugs that can preferentially kill the NSCLC harbouring L858R/T790M mutation is therefore critical. Here, we have evaluated the effects of ursolic acid, an active component isolated from herbal sources, on erlotinib-resistant H1975 cells that harbour the L858R/T790M mutation.

Experimental approach

Gene expression omnibus (GEO) profiles analyses was applied to detect differentially expressed genes in NSCLC cells harbouring EGFR mutation. AnnexinV-FITC/PI, TUNEL staining, MTT, wound healing, RT-PCR, qRT-PCR, western blots, immunostaining, dual-luciferase reporters and ChIP-PCR were utilized to investigate the effects of ursolic acid in vitro and in vivo.

Key results

The cancer/testis antigen family 45 member A2 (CT45A2) was highly expressed in H1975 cells. Ectopic expression of CT45A2 in H1975 cells increased cell proliferation and motility in vitro. Silencing the CT45A2 expression strongly attenuated H1975 cells motility and growth. The anti-cancer effect of ursolic acid was critically dependent on CT45A2 expression in H1975 cells. Ursolic acid suppressed CT45A2 gene transcription mediated by transcriptional factor TCF4 and β-catenin signalling.

Conclusions and implications

CT45A2 is a novel oncogene for NSCLC with an EGFR T790 mutation. Ursolic acid induced apoptosis and inhibited proliferation of H1975 cells by negatively regulating the β-catenin/TCF4/CT45A2 signalling pathway. Therefore, ursolic acid may be a potential candidate treatment for NSCLC harbouring the EGFR-L858R/T790M mutation."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.org/dc/terms/identifier"doi:10.1111/bph.14793"xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Chen L."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Cheng X."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Chen Y."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Hu X."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Li C."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Ma L."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Wang Y."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Zhou J."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Zhang Z."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Shan Y."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Yang K."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Zhu B."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Ji X."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Yin W."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Dai H."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/author"Tao Z."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/date"2019"xsd:gYear
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/name"Br J Pharmacol"xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/pages"4609-4624"xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/title"Ursolic acid promotes apoptosis and mediates transcriptional suppression of CT45A2 gene expression in non-small-cell lung carcinoma harbouring EGFR T790M mutations."xsd:string
http://purl.uniprot.org/citations/31322286http://purl.uniprot.org/core/volume"176"xsd:string
http://purl.uniprot.org/citations/31322286http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31322286
▶